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Background: Marine long-chain polyunsaturated fatty acids are susceptible to oxidation, generating a range of
different oxidation products with suggested negative health effects. The aim of the present study was to utilize
sensitive high-throughput transcriptome analyses to investigate potential unfavorable effects of oxidized fish oil (PV:
18 meq/kg; AV: 9) compared to high-quality fish oil (PV: 4 meq/kg; AV: 3).
Methods: In a double-blinded randomized controlled study for seven weeks, 35 healthy subjects were assigned to
8 g of either oxidized fish oil or high quality fish oil. The daily dose of EPA+DHA was 1.6 g. Peripheral blood
mononuclear cells were isolated at baseline and after 7 weeks and transcriptome analyses were performed with the
illuminaHT-12 v4 Expression BeadChip.
Results: No gene transcripts, biological processes, pathway or network were significantly changed in the oxidized
fish oil group compared to the fish oil group. Furthermore, gene sets related to oxidative stress and cardiovascular
disease were not differently regulated between the groups. Within group analyses revealed a more prominent
effect after intake of high quality fish oil as 11 gene transcripts were significantly (FDR < 0.1) changed from baseline
versus three within the oxidized fish oil group.
Conclusion: The suggested concern linking lipid oxidation products to short-term unfavorable health effects may
therefore not be evident at a molecular level in this explorative study.
Trial registration: ClinicalTrials.gov, NCT01034423
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Fish oil (FO) is associated with reduced risk of coronary
heart disease (CHD) and CHD deaths [1, 2]; thus, the
use of supplements containing n-3 fatty acids are recom-
mended for CHD prevention among those who do not
eat fish in accordance with the food recommendations
[3–5]. Long-chain polyunsaturated fatty acids (LCPU-
FAs), including n-3 fatty acids in marine oils, are suscep-
tible to oxidation, and consequently, lipid oxidation
products are generated [6–8]. For several years, the* Correspondence: mari.myhrstad@hioa.no
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maximum peroxide value (PV) of 5 meq/kg (milliequiva-
lents per kilogram) and a maximum anisidine value
(AV) of 20 [9]. Other monographs exists, such as the
European pharmacopeia recommending a PV at 5 or
10 meq/kg and an AV at 30 or 15, depending on the
content of marine n-3s. The quality of the FO, in terms
of the oxidative status, can be camouflaged by encapsu-
lation, additives, and flavorings [10], and a variation in
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marine oils and negative health effects have been raised
[10, 14, 15]. If lipid oxidation products from the diet are
absorbed in humans, these highly reactive compounds
may cause oxidative damage to macromolecules such as
proteins, carbohydrate, DNA, and lipids thereby altering
their function [16]. Highly reactive lipid compounds may
also act as signaling molecules that alter gene functions
and thereby influence health via cellular sensing mecha-
nisms [16].
Cell studies have indicated that lipid oxidation prod-
ucts are involved in pathophysiological processes due to
their reactivity [7, 17–19], and oxidized n-3 fatty acids
have been shown to increase the antioxidant defense
system and to enhance endoplasmic reticulum (ER)
stress in human intestinal Caco-2/TC7 cells [20]. Some
animal studies show serious biological effects from the
intake of oxidized lipids [21], but there are few studies
investigating the intake of oxidized lipids in concentra-
tions more similar to daily life. However, mice fed on a
high-fat diet containing weakly oxidized n-3 fatty acids
for 8 weeks increased the plasma level of n-3 oxidation
products and inflammatory markers [20]. The intake of
oxidized vegetable oils has been shown to increase the
postprandial level of plasma lipid oxidation products and
markers related to coronary vascular disease in humans
[22–26]. Discrepancies exist, and we have previously
reported that the intake of oxidized fish oil for 7 weeks
did not change the plasma levels of peroxidation products
of LCPUFAs, serum level of oxidized LDL-cholesterol,
or selected markers of oxidative stress and inflamma-
tion [27, 28]. However, lipid oxidation generates a variety
of reactive compounds [6–8], and no single biomarker
reflects the total in vivo lipid oxidation and oxidative
stress status. In addition, the circulating oxidative stress
markers may not be sensitive enough to reflect a local
change in the cellular oxidative stress status. Other ap-
proaches including more sensitive techniques to accur-
ately measure the influence of lipid oxidation products at
a molecular level are therefore required.
Transcriptome analyses examine the mRNA transcript
level in a given cell population and reflect the genes that
are actively expressed at a given time. Changes in the
transcriptome profile occur prior to changes in protein
levels. Transcriptomics has therefore shown to be a valu-
able and sensitive technique measuring early changes
related to a dietary challenge [29, 30]. The peripheral
blood mononuclear cells (PBMCs) include monocytes
and lymphocytes. In the circulation, PBMCs are exposed
to environmental factors and metabolic tissues and may
therefore reflect systemic health. It is well known that
dietary factors modulate the gene expression in PBMCs
[31–35]. In the same intervention trials as presented
here, we have previously shown that the intake of high-quality FO modulated the transcriptional profile in
human PBMCs and changes in the gene transcripts re-
lated to cell cycle, apoptosis, and ER stress were ob-
served [36]. The potential of transcriptome analyses to
detect early changes caused by a nutritional challenge
encourages us to further investigate whether the intake
of oxidized fish oil (oxFO) could alter the gene expres-
sion profile in PBMCs compared to high-quality FO in
healthy subjects.Methods
Subjects
The intervention study took place at Akershus Univer-
sity College, Norway, between September and December
2009. Thirty-five young healthy subjects (10 men and 25
women, aged 28.0 ± 8.1 years) with body mass index
(BMI) and serum lipids within the normal range were
included. Subjects enrolled in the present study are
shown in Fig. 1. The detailed description of the protocol,
participant recruitment and enrolment, inclusion and
exclusion criteria, and compliance are published in detail
elsewhere [28].Study design
This study was a part of a randomized controlled double-
blinded three-arm parallel group study, designed to inves-
tigate the health effects from the intake of fish oil with
different oxidative quality [28]. In the present study, data
from two of the intervention arms are included, as shown
in Fig. 1. All subjects received 16 capsules each day,
containing 8 g FO per day, of which 1.6 g was n-3 fatty
acids (0.7 g/d EPA + 0.9 g/d DHA). Both FOs were origin-
ating from the same batch of cod liver oil (Gadidae sp.,
TINE EPA/DHA Oil 1200) provided by TINE SA (Oslo,
Norway), and they were identical except for the oxidative
status level. The intervention group received either oxi-
dized oxFO (PV, 18 meq/kg; AV, 9; n, 18) or FO (PV,
4 meq/kg; AV, 3; n, 17) (Table 1). Further characterization
of the encapsulated oils have previously been published
[28]. The subjects were instructed to take the capsules
with food (minimum two meals). Blood samples were
collected at baseline and after 3 and 7 weeks of interven-
tion. The blood samples after 7 weeks are utilized in the
current study. Prior to the baseline visit, the subjects under-
went a 4-week marine n-3 fatty acid washout period.
During the first 3 weeks of the intervention period, the
subjects conducted a fully controlled isoenergetic diet. The
food items given did not contain any marine n-3 fatty acids,
and the food provided has previously been described in de-
tail elsewhere [28]. The intake of dietary supplements and
marine n-3 fatty acids was not allowed during the interven-
tion period.
Assessed for eligibility (n=83)
Underwent randomization (n=69)
Excluded (n=14)
•Not meeting inclusion criteria (n=8)
•Declined to praticipate before randomization (n=6)
Allocated to intervention HOSO group (n=23)Allocated to intervention FO group (n=24)
•Received allocated intervention (n=19)
•Did not receive allocated intervention (n=5)
Transcriptome
•Baseline (n=18)
•Analyzed week 7 (n=18)
Transcriptome
•Baseline (n=17)
•Analyzed week 7 (n=17)
Allocated to intervention oxFO group (n=22)
•Received allocated intervention (n=19)
•Did not receive allocated intervention (n=3)
•Lost to follow-up (n=0)
•Discontinued intervention (n=1) 
Hospitalization, not affected by this study
•Lost to follow-up (n=0)
•Discontinued intervention (n=2) 

























Fig. 1 Flow chart of the study showing subjects enrolled, lost during follow-up, and number of subjects included in the statistical analysis at the
baseline and after 3 weeks of fish oil supplementation. FO group fish oil group, oxFO oxidized fish oil group, HOSO high-oleic sunflower oil group
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After blood collection, the PBMCs were isolated by using
the BD Vacutainer Cell Preparation tubes according to the
manufacturer’s instructions (Becton, Dickinson and Com-
pany, NJ 07417, USA). Pellets were frozen and stored at
−80 °C for further RNA isolation.Table 1 Characterization of the encapsulated oil
oxFO FO
Omega-3 fatty acids
EPA (20: 5n-3) (g/100 g) 9.1 9.0
DHA (22: 6n-3) (g/100 g) 11.2 11.1
DPA (22 : 5n-3) (g/100 g) 1.1 1.1
Oxidation level
PV (meq/kg) 18 4
AV 9 3
TOTOX (2 × PV + AV) 45 11
Volatile oxidation products of omega-3 FA
Pentanal (μg/100 g) 137.8 6.2
1-penten-3-ol (μg/100 g) 132.4 12.8
oxFO oxidized fish oil, FO fish oil, EPA eicosapentaenoic acid, DHA
docosahexaenoic acid, DPA docosapentaenoic acid, PV peroxide value, AV
anisidine value, TOTOX total oxidationTotal RNA was isolated from all PBMC samples using
the RNeasy Mini Kit (Qiagen) with lysis buffer-added β-
mercaptoethanol according to the manufacturer’s in-
structions and stored at −80 °C. RNA quantity and qual-
ity measurements were performed using the ND 1000
Spectrophotometer (Saveen & Werner AB, Limhamn,
Sweden) and Agilent Bioanalyser (Agilent Technologies
Inc., CA 95051, USA), respectively. One sample had a
RNA integrity number (RIN) score of 3.3, and all other
samples were above 8 (mean = 9.6). Nanodrop analysis
did not indicate any contamination in the RNA samples.
The total numbers of monocytes and lymphocytes were
measured in EDTA plasma at a routine laboratory (Fürst
Medical Laboratory, Oslo, Norway).
Microarray hybridization
Labeled extracts were prepared using the Illumina Total-
Prep RNA Amplification Kit (Illumina Inc., CA 92122,
USA) according to manufacturer’s instructions. The la-
beled extracts were hybridized on an Illumina HumanHT-
12 v4 Expression BeadChip and scanned on an Illumina
HiScan microarray scanner (Illumina Inc., CA 92122,
USA). Illumina GenomeStudio was used to transform
bead-level data to probe-level intensity values and statistics,
which were exported raw (unfiltered, non-normalized) for
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manual quality control step was performed, looking at
density plots and hierarchical clustering of raw probe
densities. All samples, including the one with RIN < 8 were
displaying good characteristics and included in further
analysis.
Microarray data analyses
The Illumina intensities were quantile-normalized. To
improve statistical power, probes without a detectable
expression (detection p value > 0.01) in at least 10 % of
the samples were discarded from further analysis. From
the 48,000 probes presented on the HumanHT-12 v4
microarray, 21,236 were defined as expressed in the
PBMCs and included in the analyses. Changes in gene
expression were obtained by calculating log2 ratios be-
tween the baseline and after 7-week intensities, and the
two intervention groups were compared with regard to
this ratio. Differentially expressed genes between groups
were identified using the Linear Models for Microarray
(Limma) data [37] package from Bioconductor (http://
www.bioconductor.org) performed with the R software.
For the within-group analyses, the log2 intensities at
7 weeks and baseline were compared and differentially
expressed genes within each group were identified using
Limma.
Genes with a nominal p value < 0.05 were defined as
differentially regulated and subjected to further gene
ontology, pathway, and network analyses using the Data-
base for Annotation, Visualization and Integrated Dis-
covery (DAVID) software tool version 6.7 (http://
david.abcc.ncifcrf.gov) and MetaCore (GeneGo, division
of Thomson Reuters, St. Joseph, MI, USA). For the DA-
VID analyses, the list of differential regulated genes was
compared to a reference list of Homo sapiens and bio-
logical processes containing more than 10 genes and a
false discovery rate (FDR) q value < 0.05 were considered
significantly modulated. Pathways and networks identi-
fied in MetaCore with a FDR q value < 0.05 were consid-
ered significantly modulated.
Gene Set Enrichment Analyses (GSEA) (http://www.
broad.mit.edu/gsea/) were applied on the genes de-
fined as expressed in PBMCs (21,236) for comparison
of the transcriptome profile between the two groups.
The gene sets in the collection of C2 canonical path-
ways (cps) and C5 biological process (bp) from Mo-
lecular Signatures Database (MSigDB v5.0) were used
separately. In addition, six gene set collections associated
with oxidative stress and cardiovascular disease were cre-
ated using a gene set browser (MSigDB v5.0) on the Broad
Institute website (http://software.broadinstitute.org/gsea/
msigdb/search.jsp) using the keywords stepwise: “oxidative
AND stress,” “oxidative AND damage,” “hypoxi*,” “cardio-
vascular*,” “immune AND response,” and “inflammation”.Permutation (1000) was performed on phenotypes, and
gene sets were defined as significantly changed when FDR
q value < 0.25 as recommended for explorative analyses by
the Broad Institute (http://www.broad.mit.edu/gsea/). The
minimum information about a microarray experiment
(MIAME) standards [38] were followed in the analysis and
storage of data.
Results
The subjects included in the study were young and
middle-aged adults (28.0 ± 8.1 years), and the character-
istics of the subjects have previously been described [28].
In short, no differences in age, BMI, or serum lipids
were observed between the oxFO (n = 18) and the FO
groups (n = 17) at baseline or after 7 weeks of interven-
tion (Table 2). Additionally, no differences in plasma
fatty acids, including the level of long-chained n-3 fatty
acids, were observed between the two groups after the
intervention period as previously described [28]. The
number of monocytes and lymphocytes were the same
between the two groups at baseline and after 7 weeks of
intervention (data not shown).
Gene expression profiling in PBMCs
Microarray hybridization was performed on RNA from
PBMCs collected at baseline and after 7 weeks of sup-
plementation with oxFO (n = 18) or FO (n = 17).
The differences in gene expression between the two
groups were determined by a moderated t test (Limma),
by comparing the relative change from baseline to 7 weeks
of intervention among the 21,236 expressed genes. In
total, 402 gene transcripts were found to be differentially
expressed between the two intervention groups (p < 0.05)
(Additional file 1: Table S1). However, no gene transcripts
were significantly differentially expressed (FDR q value
<0.1) between the two groups when adjusting for multiple
testing (Additional file 1: Table S1). To identify differences
across the two intervention groups related to biological
processes, pathways, and networks, we analyzed functional
relationships among the 402 differentially expressed gene
transcripts obtained with Limma (p < 0.05). There was no
significantly regulated biological processes, pathways, or
networks between the two groups after 7 weeks using the
software tools DAVID or MetaCore (FDR q value < 0.05,
data not shown).
GSEA was used to test whether groups of genes in-
volved in the same biological process or pathway were
changed after intake of oxFO compared to FO among all
the 21,236 defined expressed genes. We could not detect
any differences between the two groups when using the
C2 cp or the C5 bp gene set collection (MSigDB v5.0)
(FDR q value < 0.25) (Additional files 2 and 3: Table S2
and S3). In addition, GSEA was used to test whether
gene sets associated with oxidative stress, inflammation,
Table 2 Baseline characteristic and serum blood values at
baseline











Male/female (n) 5/12 5/13
Age (year) 25 23–32 22 21–28 0.202
BMI (kg/m2) 22.1 2.5 22.2 1.7 0.849
Total-C (mmo/l) 4.6 0.8 4.7 0.9 0.646
LDL-C (mmol/l) 2.5 0.8 2.7 0.8 0.431
HDL-C (mmol/l) 1.5 0.3 1.4 0.4 0.598
TG (mmol/l) 0.8 0.7–0.9 0.9 0.5–1.5 0.921
Data are presented as mean and standard deviation (SD) or median
(25–75 percentile), and differences between the groups were calculated using
independent-samples t test or Mann-Whitney U test. p values <0.05 were
considered significant
oxFO oxidized fish oil, FO fish oil, Total-C total cholesterol, LDL-C low-density
lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol,
TG triglycerides
Table 4 Significantly changed gene transcripts identified with
Limma (FDR q value < 0.1) within the oxFO or FO group after
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ing the intervention in the oxFO group compared to the
FO group. However, these gene sets were not signifi-
cantly changed in the two FO groups (Table 3).
A moderated t test (Limma) was used to identify regu-
lated gene transcripts within the two intervention groups
separately, by comparing the transcript level at 7 weeks to
the level at baseline. In total, 345 and 667 gene transcripts
(p < 0.01) among the defined expressed genes were regu-
lated within the oxFO or FO group after 7 weeks, respect-
ively. Of these, 3 (oxFO) and 11 (FO) gene transcripts
were significantly regulated when adjusting for multiple
testing (FDR q value <0.1) (Table 4). Two of the gene tran-
scripts (CD55 and SNORD13) were overlapping and
significantly downregulated in both groups. BAK1 mRNATable 3 GSEA analyses. Gene sets associated with oxidative
stress and cardiovascular diseases created using a gene set
browser (Molecular Signatures Database v5.0)
GSEA gene set
collectiona
# gene sets in
collectionb
Regulated gene sets oxFO vs FO
(FDR q value < 0.25)










# number of gene sets, FDR false discovery rate
* indicates truncated search words
aCollections of gene sets were obtained using a gene set browser from the
Broad Institute website http://software.broadinstitute.org/gsea/msigdb/
search.jsp by the listed keywords
bNumber of gene sets passing the gene set size filter (min 10 genes, max 500
genes)was significantly increased from the baseline within the
oxFO group only. In addition, the gene transcripts shown
in Table 2 were regulated in the same direction within the
two groups after 7 weeks. To explore the biological pro-
cesses modulated within each intervention group, the lists
of 345 and 667 changed gene transcripts were subjected
to functional analyses separately. Several biological pro-
cesses were significantly modulated within each interven-
tion group (Table 5). Modulated biological processes after
7 weeks within the oxFO group and FO group were
related to translation elongation, translation, and apop-
tosis, whereas only cell cycle was modulated after intake
of oxFO (Table 5).
Discussion
In the present study, the consumption of oxFO for 7 weeks
did not alter the transcriptome profile in PBMCs in
healthy subjects when compared to the intake of high-
quality FO in a randomized controlled intervention study.
Within-group analyses revealed a more prominent effect
after intake of high-quality FO as more gene transcripts
were changed from the baseline than within the oxFO
group. The current study is to our knowledge the first to
investigate effects at a molecular level after the intake of
oxFO using high-throughput sensitive transcriptome
analyses.
The intake of lipid oxidation products may disturb the
normal redox state of the cell, alter normal cell function
and signaling [7, 16], and ultimately lead to modulation
of gene expression [39]. In a previous study with mice,
the intake of moderately oxidized n-3 PUFA for 8 weeks
induced oxidative stress in the intestine and enhanced7 weeks of intervention
FC within groups from baseline FDR q value
Gene oxFO FO oxFO FO
CD55 0.83 0.85 0.00 0.01
SNORD13 0.63 0.60 0.04 0.01
VNN2 0.90 0.80 0.59 0.01
SNORA12 0.82 0.70 0.59 0.03
RSBN1L 0.92 0.88 0.59 0.03
VNN2 0.87 0.77 0.62 0.04
LOC80054 1.05 1.09 0.62 0.09
POLR1D 0.96 0.90 0.66 0.09
SERPINB9 0.98 0.85 0.92 0.09
RAB11FIP2 0.99 0.90 0.92 0.09
SNORD12C 0.91 0.88 0.59 0.10
BAK1 1.13 1.08 0.04 0.24
oxFO oxidized fish oil, FO fish oil, FC fold change from baseline, FDR false
discovery rate
Table 5 Enriched biological processes within the oxFO and FO
groups after 7 weeks of intervention among the regulated
genes obtained with Limma analysis (p < 0.05)




GO:0006414~translational elongation 9.52 0.00
GO:0007049~cell cycle 2.48 0.02
GO:0006412~translation 3.49 0.03
GO:0000280~nuclear division 4.08 0.07
GO:0007067~mitosis 4.08 0.07
GO:0000087~M phase of mitotic cell cycle 4.01 0.08
GO:0048285~organelle fission 3.92 0.10
GO:0000278~mitotic cell cycle 3.12 0.11
GO:0022402~cell cycle process 2.38 0.85
GO:0051301~cell division 3.04 1.19
GO:0022403~cell cycle phase 2.63 1.23
GO:0042981~regulation of apoptosis 1.99 2.62
GO:0043067~regulation of programmed cell
death
1.97 2.98
GO:0010941~regulation of cell death 1.97 3.13
GO:0000279~M phase 2.73 3.15














GO:0060548~negative regulation of cell
death
2.48 0.18
GO:0043067~regulation of programmed cell
death
1.88 0.23
GO:0010941~regulation of cell death 1.87 0.25
GO:0042981~regulation of apoptosis 1.85 0.39
GO:0042254~ribosome biogenesis 3.36 2.73
GO:0006917~induction of apoptosis 2.21 4.20
GO:0012502~induction of programmed cell
death
2.21 4.32
oxFO oxidized fish oil, FO fish oil, BP biological processes, FDR false
discovery rate
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lyses showed an increase in the glucose-regulated pro-
tein 78 (GRP78) and glutathione peroxidase 2 (GPx2)
mRNA [20]. We have previously not been able to detect
changes in markers of oxidative stress such as urinary 8-
iso-PGF2a, plasma a-tocopherol, plasma 4-hydroxy-2-hexenal and plasma 4-hydroxy-2-nonenal or glutathione,
CAT activity, and GPx activity in erythrocytes or inflam-
matory markers in the same study after intake of oxFO
compared to high-quality FO [27, 28]. Furthermore, the
intake of oxFO, containing lipid oxidation products, did
not alter biological processes or gene sets related to oxida-
tive stress when compared to fish oil in the current study.
When the groups were analyzed separately, the mRNA
level of BAK1 was significantly increased from baseline
within the oxFO group. The BAK1 protein is localized
to the mitochondria and functions to induce apoptosis.
This protein also interacts with the tumor suppressor
p53 after exposure to cellular stress [40], and the in-
creased BAK1 mRNA level could be caused by the
intake of lipid oxidation products in the oxFO group.
BAK and BAX were recently shown to be involved in
eicosanoid metabolism independent of apoptotic func-
tions [41]. The increase in BAK1 mRNA may therefore
be related to the eicosanoid precursor EPA and DHA,
presented in equal amounts in the two fish oils. BAK1
mRNA was also increased from the baseline within the
FO group, although not significantly (Table 4), and bio-
logical processes related to apoptosis were regulated
within both fish oil groups.
Biological processes related to translation elongation,
translation, and apoptosis were enriched within both
groups, while biological processes related to cell cycle was
only enriched within the oxFO group. However, we have
previously shown that the intake of high-quality FO
regulated gene transcripts related to apoptosis, cell cycle,
and ER stress when compared to the intake of high-oleic
sunflower oil [36]. Our data is in accordance with Bou-
wens et al.’s, who also demonstrated that the expression of
genes involved in pathways related to processes such as
transcription, translation, and cell cycle were regulated in
PBMCs after the intake of FO (1.8 g/day EPA+DHA) for
26 weeks in elderly subjects [31]. Thus, processes related
to the translation, apoptosis, and cell cycle may be modu-
lated after the intake of fish oil independent of oxidative
status. These processes and pathways are involved in
normal cellular functions and may ultimately influence
whole body health. We did not detect any regulated
pathways or processes related to lipid metabolism, antioxi-
dant defense, and inflammation as previously reported after
n-3 supplementation [31, 42–44]. This could be explained
by the inclusion of healthy subjects in the current study,
and the results may be different in subjects with elevated
levels of inflammation, oxidative stress, or serum lipids.
CD55 was downregulated from the baseline within both
groups and independent of the oxidative status of the fish
oils. CD55 is part of the complement system and has been
suggested to play a role in the pathogenesis of atheroscler-
osis [45]. CD55 deficiency has also been shown to protect
apoE−/− micefrom atherosclerosis [46]. The downregulation
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nisms by which fish oil can exert its beneficial effect.
The changes in the oxidative status of the oil as mea-
sured by increased PV and AV occur prior to a measur-
able reduction in the concentration of fatty acids. Thus,
the oxidized and the non-oxidized FO contained an
equal amount of fatty acids, including n-3 fatty acids
(Table 1). The similar transcriptome profile may there-
fore be explained by the similar fatty acid profile of the
FOs [28] as they originated from the same batch.
Conflicting results related to the prevention of cardio-
vascular diseases by marine LCPUFAs have recently been
published [47]. It has been suggested that the oxidation of
the marine oils may be responsible for the lack of effect
[15]. A recent study investigating the effect of omega-3
supplements with different oxidation level on circulating
lipid parameters showed a reduction in plasma triglycer-
ides independent of the oxidative status of the fish oil.
However, a beneficial effect on plasma total cholesterol
was only evident in the group consuming less oxidized
fish oil [48]. In the current study, a more prominent effect
was evident after the intake of FO as 11 gene transcripts
were significantly (FDR < 0.1) changed from baseline
whereas 3 within the oxFO group (Table 4). Whether this
is related to the oxidative status of the fish oils is currently
not known and needs further investigations.
The present study was originally designed to investigate
the effect of oxFO on the circulating markers of oxidative
stress, inflammation, and plasma lipids compared to high-
quality FO, and the power of the study was calculated
based on the relative change in plasma n-3 compared to
the high-oleic sunflower oil [28]. We cannot rule out the
possibility that the current study lacks the power to detect
differences between the two FO groups when it comes to
the transcriptome profile. However, transcriptome ana-
lyses in PBMCs represent a sensitive high-throughput
method to detect changes caused by diet [30]. To increase
the power in the current study, we included analyses
where genes were grouped based on involvement in the
same biological process, pathway, or network.
The strengths of the present study are that the study
design was performed as a blinded randomized con-
trolled trial with high compliance, as described in more
detail elsewhere [28]. The transcriptome analyses have
been performed with an exploratory approach where the
identification of regulated gene transcripts, biological
processes, and networks was done with several data ana-
lysis strategies. The major limitation is the relatively low
daily dose of oxidized lipids (PV/AV) administered and
the relatively short intervention period. The study group
included healthy subjects, and we cannot rule out that
by using another study group more susceptible to the
intake of oxFO, this would have led to different results.
There is also a chance that other cellular compartmentsor tissues such as the intestine may have been affected
by the intake of oxFO in the present study.
Conclusion
By using a transcriptome approach, we aimed to investi-
gate the effects at the molecular level prior to changes in
circulating markers. The results demonstrate that the
short-term consumption of oxidized fish oil in healthy
subjects did not alter the transcriptome profile in PBMCs
compared to the intake of high-quality FO. Whether these
results are applicable for other oxidized marine oils, lon-
ger interventions, or valid in subjects with elevated levels
of inflammation and oxidative stress needs to be addressed.
Additional files
Additional file 1: Table S1. Significantly changed gene transcripts
(p > 0.05) between the oxFO and FO groups determined by a moderated
t test (Limma), by comparing the relative change from the baseline to
7 weeks of intervention. oxFO oxidized fish oil, FO fish oil, FC fold change
from baseline, FDR false discovery rate. (XLSX 34 kb)
Additional file 2: Table S2. GSEA analyses applied on the genes
defined as expressed in PBMCs (21,236) for comparison of the
transcriptome profile between the two groups oxFO vs FO. Gene sets in
the C2 cp collection were used. ES enrichment score. NES normalized
enrichment score. (XLSX 33 kb)
Additional file 3: Table S3. GSEA analyses applied on the genes
defined as expressed in PBMCs (21,236) for comparison of the
transcriptome profile between the two groups oxFO vs FO. Gene sets in
the C5 bp collection were used. ES enrichment score, NES normalized
enrichment score. (XLSX 25 kb)
Abbreviations
AV: anisidine value; CHD: coronary heart disease; FC: fold change; FDR: false
discovery rate; FO: fish oil; LCPUFAs: long-chain polyunsaturated fatty acids;
meq/kg: milliequivalents per kilogram; oxFO: oxidized fish oil;
PBMCs: peripheral blood mononuclear cells; PV: peroxide value.
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